-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On June 22, the National Pharmacopoeia Commission announced 8 draft chemical standards: paracetamol and pseudoephedrine tablets (Ⅲ), paracetamol and pseudoephedrine tablets (Ⅱ), paracetamol and pseudoephedrine tablets, trimethoprim injection , Trimethoprim Tablets, Trimethoprim, Cefazolin Sodium for Injection, Cefazolin Sodium; 1 draft standard of traditional Chinese medicine: Xiaoer Huadu Powder
A Chinese medicine
A Chinese medicine1.
Our committee intends to revise the national drug standard for Xiaoer Huadu Powder, the standard number: "Chinese Pharmacopoeia" 2020 edition.
Contact: Li Hao, Ni Long
Phone: 010-67079538, 010-67079592
Email: zy@chp.
Mailing address: Office of the National Pharmacopoeia Commission, Building 11, Fahua South Lane, Dongcheng District, Beijing
Post Code: 100061
Two chemicals
Two chemicals1.
Our committee plans to revise the national drug standard of paracetamol and pseudoephedrine tablets (Ⅲ), the standard number: WS1-(X-440)-2003Z-2007, in order to ensure the scientificity, rationality and applicability of the standard, it will now be revised Paracetamol and pseudoephedrine tablets (Ⅲ) The national drug standard is publicized to solicit opinions from all walks of life (see attachment for details)
Contacts: 1.
Tel: 1, 010-67079535; 2, 010-67079553
Email: yueruiqi@chp.
Mailing address: Office of the National Pharmacopoeia Commission, Building 11, Fahua South Lane, Dongcheng District, Beijing
Post Code: 100061
2.
Our committee plans to revise the national drug standard of paracetamol and pseudoephedrine tablets (Ⅱ), the standard number: WS1-(X-113)-2004Z.
Contacts: 1.
Tel: 1, 010-67079535; 2, 010-67079553
Email: yueruiqi@chp.
Mailing address: Office of the National Pharmacopoeia Commission, Building 11, Fahua South Lane, Dongcheng District, Beijing
Post Code: 100061
3.
Our committee plans to revise the national drug standard of paracetamol and pseudoephedrine tablets, the standard number: WS1-(X-440)-2003Z.
Contacts: 1.
Tel: 1, 010-67079535; 2, 010-67079553
Email: yueruiqi@chp.
Mailing address: Office of the National Pharmacopoeia Commission, Building 11, Fahua South Lane, Dongcheng District, Beijing
Post Code: 100061
4.
Trimethoprim injection
Our committee plans to revise the national drug standard for trimethoprim injection.
To ensure the scientificity, rationality and applicability of the standard, the proposed revision of the national drug standard for trimethoprim injection is now soliciting opinions from all walks of life (see attachment for details) )
.
The publicity period is three months from the date of publication
.
Please carefully research and verify.
If you have any objections, please submit feedback in a timely manner, with relevant instructions, experimental data and contact information
.
Letters from relevant units must be stamped with official seals, personal letters must be signed by themselves, and the electronic version must be sent to the designated mailbox
.
Contact: Wang Zhijun; Zeng Yi
Phone: 010-67079559; 010-67079553
Email: wangzhijun@chp.
org.
cn
Mailing address: Office of the National Pharmacopoeia Commission, Building 11, Fahua South Lane, Dongcheng District, Beijing
Post Code: 100061
5.
Trimethoprim tablets
Our committee plans to revise the national drug standards for trimethoprim tablets.
In order to ensure the scientificity, rationality and applicability of the standards, the proposed revision of the national drug standards for trimethoprim tablets is now publicly solicited for comments from all sectors of the society (see attachment for details)
.
The publicity period is three months from the date of publication
.
Please carefully research and verify.
If you have any objections, please submit feedback in a timely manner, with relevant instructions, experimental data and contact information
.
Letters from relevant units must be stamped with official seals, personal letters must be signed by themselves, and the electronic version must be sent to the designated mailbox
.
Contact: Wang Zhijun; Zeng Yi
Phone: 010-67079559; 010-67079553
Email: wangzhijun@chp.
org.
cn
Mailing address: Office of the National Pharmacopoeia Commission, Building 11, Fahua South Lane, Dongcheng District, Beijing
Post Code: 100061
6.
Trimethoprim
Our committee plans to revise the national drug standard for trimethoprim.
To ensure the scientificity, rationality and applicability of the standard, the proposed revision of the national drug standard for trimethoprim is now publicly solicited for opinions from all walks of life (see attachment for details)
.
The publicity period is three months from the date of publication
.
Please carefully research and verify.
If you have any objections, please submit feedback in a timely manner, with relevant instructions, experimental data and contact information
.
Letters from relevant units must be stamped with official seals, personal letters must be signed by themselves, and the electronic version must be sent to the designated mailbox
.
Contact: Wang Zhijun; Zeng Yi
Phone: 010-67079559; 010-67079553
Email: wangzhijun@chp.
org.
cn
Mailing address: Office of the National Pharmacopoeia Commission, Building 11, Fahua South Lane, Dongcheng District, Beijing
Post Code: 100061
7.
Cefazolin Sodium for Injection
Our committee plans to revise the national drug standard of cefazolin sodium for injection.
In order to ensure the scientificity, rationality and applicability of the standard, the proposed revision of the national drug standard for cefazolin sodium for injection is now soliciting opinions from all walks of life (see attachment for details) )
.
The publicity period is three months from the date of publication
.
Please carefully research and verify.
If you have any objections, please submit feedback in a timely manner, with relevant instructions, experimental data and contact information
.
Letters from relevant units must be stamped with official seals, personal letters must be signed by themselves, and the electronic version must be sent to the designated mailbox
.
Contact: Wang Zhijun; Zeng Yi
Phone: 010-67079559; 010-67079553
Email: wangzhijun@chp.
org.
cn
Mailing address: Office of the National Pharmacopoeia Commission, Building 11, Fahua South Lane, Dongcheng District, Beijing
Post Code: 100061
8.
Cefazolin Sodium
Our committee intends to revise the national drug standard of cefazolin sodium.
To ensure the scientificity, rationality and applicability of the standard, the proposed revision of the national drug standard of cefazolin sodium is now publicly solicited for opinions from all walks of life (see attachment for details)
.
The publicity period is three months from the date of publication
.
Please carefully research and verify.
If you have any objections, please submit feedback in a timely manner, with relevant instructions, experimental data and contact information
.
Letters from relevant units must be stamped with official seals, personal letters must be signed by themselves, and the electronic version must be sent to the designated mailbox
.
Contact: Wang Zhijun; Zeng Yi
Phone: 010-67079559; 010-67079553
Email: wangzhijun@chp.
org.
cn
Mailing address: Office of the National Pharmacopoeia Commission, Building 11, Fahua South Lane, Dongcheng District, Beijing
Post Code: 100061
